Rhenium(I) Tricarbonyl Complexes of meso-Tetraaryl-21,23-diheteroporphyrins

Metal Complexes of Porphyrinoids Containing Nonpyrrolic Heterocycles

The replacement of one or more pyrrolic building block(s) of a porphyrin by a nonpyrrolic heterocycle leads to the formation of so-called pyrrole-modified porphyrins (PMPs), porphyrinoids of broad structural variability. The wide range of coordination environments (type, number, charge, and architecture of the donor atoms) that the pyrrole-modified frameworks provide to the central metal ions, the frequent presence of donor atoms at their periphery, and their often observed nonplanarity or conformational flexibility distinguish the complexes of the PMPs clearly from those of the traditional square-planar, dianionic, N₄-coordinating (hydro)porphyrins. Their different coordination properties suggest their utilization in areas beyond which regular metalloporphyrins are suitable. Following a general introduction to the synthetic methodologies available to generate pyrrole-modified porphyrins, their general structure, history, coordination chemistry, and optical properties, this Review highlights the chemical, electronic (optical), and structural differences of specific classes of metalloporphyrinoids containing nonpyrrolic heterocycles. The focus is on macrocycles with similar "tetrapyrrolic" architectures as porphyrins, thusly excluding the majority of expanded porphyrins. We highlight the relevance and application of these metal complexes in biological and technical fields as chemosensors, catalysts, photochemotherapeutics, or imaging agents. This Review provides an introduction to the field of metallo-PMPs as well as a comprehensive snapshot of the current state of the art of their synthesis, structures, and properties. It also aims to provide encouragement for the further study of these intriguing and structurally versatile metalloporphyrinoids.

New approach for the synthesis of water soluble fac-[MI(CO)3]+ bis(diarylphosphino)alkylamine complexes (M = 99Tc, Re)

A novel proof-of-concept is reported to modify the water solubility and potential biological effects of a bis(diphenylphosphino)alkylamine (PNP) ligand and the corresponding metal complex, by introducing an amine group on the outer periphery of the pendant ligand arm. Thus, a tertiary butoxycarbonyl protected N'-Boc-ethylenediamine-N,N-bis(diphenylphosphino) (N'-Boc-PNP) ligand (1) was synthesized by reacting the protected ethylenediamine and chlorodiphenylphosphine in a 1 : 2 molar ratio. The corresponding fac-[Re(CO)₃(N'-Boc-PNP)Br] (1A) complex was then obtained by reacting N'-Boc-PNP (1) with (Et₄N)₂fac-[Re(CO)₃Br₃] in equimolar amounts in DCM at 50 °C. De-protection of the N'-Boc pendant amine group in 1A with TFA leads to fac-[Re(NH₃⁺-PNP)(CO)₃Br]·CF₃COO^- (1B) which is soluble in D₂O (>0.05 M). Treating 1B with saturated aqueous NaHCO₃ yields fac-[Re(NH₂-PNP)(CO)₃Br]·MeOH (1C) in near quantitative yield. Although both 1A and 1C are not soluble in D₂O, addition of TFA easily generates 1B (³¹P NMR), confirming the formation of the protonated amine. Isolation of fac-[⁹⁹Tc(CO)₃(N-Boc-PNP)(Cl)] (1D) confirmed that the rhenium and technetium (⁹⁹Tc) can be easily interchanged in this process. Reported are hence the unique rhenium series of compounds 1A, 1B and 1C and the corresponding technetium complex 1D, unequivocally characterized by single crystal XRD, as well as IR and ¹H NMR spectroscopy. Preliminary antimicrobial evaluation indicates that ligand 1 and its respective rhenium complexes (1A-1C) were not active against selected fungi (Candida albicans and Cryptococcus neoformans) and bacteria (Escherichia coli, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa and Staphylococcus aureus). These types of ligands and complexes therefore present themselves as excellent radio models for further evaluation using ¹⁸⁶Re, ¹⁸⁸Re and ^99mTc to potentially study the radiotoxicity of appropriately designed complexes.

Exploring preliminary structural relationships and mitochondrial targeting of fac-[MI(CO)3]-bis(diarylphosphino)alkylamine complexes (M = 99Tc, Re)

Preliminary structural relationships in fac-[MI(CO)3]-bis(diarylphosphino)alkylamine complexes (M = 99Tc, Re), antimicrobial and mitochondrial targeting are reported.

Targeted synthesis of meso-aryl substituted aromatic trans-doubly N-confused dithia/diselena [18] porphyrins (1.1.1.1) with NIR absorption: spectroscopic and theoretical characterization

High yield synthesis and spectroscopic isolation of two hitherto unknown highly stable single conformers of meso-aryl substituted dithia/diselena trans-doubly N-confused porphyrins with fully π-conjugated [18] annulene structures are reported. In-depth solution state spectroscopic measurements and DFT level theoretical calculations strongly show the distinct aromaticity with strong NIR absorption of these new macrocycles.

Facile Redox-Induced Aromatic-Antiaromatic Interconversion of a β-Tetracyano-21,23-Dithiaporphyrin under Ambient Conditions

Facile redox-induced aromatic-antiaromatic interconversions were accomplished by using β-tetracyano-21,23-dithiaporphyrin (CN₄ S₂ Por). Introduced cyano groups not only increased the reduction potential of the porphyrin core but also stabilized the antiaromatic isophlorin (CN₄ S₂ Iph) by π conjugation. The reduction of CN₄ S₂ Por with hydrazine in polar solvents quantitatively affords CN₄ S₂ Iph, even under ambient conditions. CN₄ S₂ Iph retains a nearly planar conformation and exhibits considerable antiaromaticity. Aerobic oxidation of CN₄ S₂ Iph to CN₄ S₂ Por occurs in nonpolar solvents. This study was conducted to contribute to the understanding of the structure-antiaromaticity relationship.

Design of Rhenium Compounds in Targeted Anticancer Therapeutics

Background:

Many rhenium (Re) complexes with potential anticancer properties have been synthesized in the recent years with the aim to overcome the clinical limitations of platinum agents. Re(I) tricarbonyl complexes are the most common but Re compounds with higher oxidation states have also been investigated, as well as hetero-metallic complexes and Re-loaded self-assembling devices. Many of these compounds display promising cytotoxic and phototoxic properties against malignant cells but all Re compounds are still at the stage of preclinical studies.

Methods:

The present review focused on the rhenium based cancer drugs that were in preclinical and clinical trials were examined critically. The detailed targeted interactions and experimental evidences of Re compounds reported by the patentable and non-patentable research findings used to write this review.

Results:

In the present review, we described the most recent and promising rhenium compounds focusing on their potential mechanism of action including, phototoxicity, DNA binding, mitochondrial effects, oxidative stress regulation or enzyme inhibition. Many ligands have been described that modulating the lipophilicity, the luminescent properties, the cellular uptake, the biodistribution, and the cytotoxicity, the pharmacological and toxicological profile.

Conclusion:

Re-based anticancer drugs can also be used in targeted therapies by coupling to a variety of biologically relevant targeting molecules. On the other hand, combination with conventional cytotoxic molecules, such as doxorubicin, allowed to take into profit the targeting properties of Re for example toward mitochondria. Through the example of the diseleno-Re complex, we showed that the main target could be the oxidative status, with a down-stream regulation of signaling pathways, and further on selective cell death of cancer cells versus normal cells.

The rhenium(I)-diselenoether anticancer drug targets ROS, TGF-β1, VEGF-A, and IGF-1 in an in vitro experimental model of triple-negative breast cancers

The rhenium(I)-diselenoether complex (Re-diSe) is a rhenium tricarbonyl-based drug chelated by a diselenoether ligand. In this work, we compared its inhibitory effects on the hormone-independent MDA-MB231cancer line and other different cancer cell lines after an exposure time of 72 h by MTT assays. The sensitivity of MDA-MB231 was in the same range than the hormone-dependent MCF-7 breast cancer, the PC-3 prostate and HT-29 colon cancer cells, while the A549 lung and the HeLa uterine cancer cells were less sensitive. We compared the inhibitory effects of Re-diSe and of its diselenide ligand (di-Se) on MDA-MB231 and a normal HEK-293 human embryonic cell line, after 72 h and 120 h of exposure. The cytotoxicity was also studied by flow cytometry using ethidium bromide assays, as well as the effects on the ROS production by DFCA-test, while the levels of TGF-β1, VEGF-A, IGF-1 were addressed by ELISA tests. The dose required to inhibit 50% of the proliferation (IC₅₀) of MDA-MB231 breast cancer cells decreased with the time of exposure to 120 h, while the free ligand (di-Se) was found poorly active, demonstrating the important role of Re in this Re-diSe combination. The cytotoxic effects of Re-diSe were highly selective for cancer cells, with a significant increase of the number of dead cancer cells at 5 μM for an exposure time of 120 h, while normal cells were not affected. A remarkable and significant decrease of the production of ROS together with a decrease of VEGF-A, TGF-β1, and IGF-1 by the cancer cells were also observed when cancer cells were exposed to Re-diSe.

Ambient and high-pressure kinetic investigation of methanol substitution in fac-[Re(Trop)(CO)3(MeOH)] by different monodentate nucleophiles

First report of high-pressure methanol substitution by entering monodentate L forms fac-[Re(CO)₃(Trop)(L)] {ΔV^≠_(kL) = +9 – +14 cm⁻³ mol⁻¹}, indicating dissociative/dissociative interchange activation.

Hybrid Macrocycles of Subporphyrins and Triphyrins

The dibenzofuran/dibenzothiophene-based nonaromatic hybrid macrocycles, exhibiting the features of both contracted macrocycles, subporphyrins and triphyrins, have been synthesized under simple reaction conditions using readily available precursors. The monoanionic new macrocyclic ligands with three donor atoms, such as two pyrrole nitrogens and one dibenzofuran oxygen or dibenzothiophene sulfur, readily form Re(I) complexes.